PHASE I TRIAL OF ANTI-B4 BLOCKED RICIN (B4bR) GIVEN AS A 28 DAY CONTINUOUS INFUSION (CI).

Autor: Murray, J. L., McLaughlin, P. W., Rosenblum, M. G., Brewer, H., LeBherz, D., O'Brien, S., Hagemeister, F. B., Esseltine, D., Keating, M.
Zdroj: Journal of Immunotherapy; Oct1994, Vol. 16 Issue 3, p242-242, 1p
Databáze: Complementary Index